Bilateral temporal non inflamatory nodules following poly-L-lactic acid PLLA inj

Injectables
Follow this case

Anonymous

novembre 16, 2025 21:24

Patient description

52-year-old female patient who developed bilateral temporal nodules after Poly-L-lactic acid injection. Her medical history is unremarkable, and she reports no known comorbidities

Case description

On June 17th, 2025, I injected one vial of Lanluma V (210mg/17ml of PLLA) for a full face treatment using a 22G canula. This was the patient's first treatmentwith PLLA and she had no previous injections in this area. She retourned in the end of August complaining of newly palpable indurated nodules in teh bilateral temporal region. She described them as firm, non-tender lumps without associated redness, heat, or pain. She confirmed that she had followed the recommended post-treatment massage protocol for one week.

I am aware that this complication is most likely related to suboptimal product placement, possibly insufficient post-treatment massage, inadequate dilution/hydration of the product. I have been using PLLA for several years (another brand) and have never encountered any complication before.

Since late August I have seen the patient at least 10 times.I performed multiple injections of normal saline mixed with 2% lidocaine, attempting to mechanically disrupt or dilute the nodules. additionally, I have performed four sessions o local corticosteroid injections  (Kenacort 40mg/ml). Despite these interventions the improvement has been minimal. The patient is extremely anxious, despite my explanation that PLLA nodules can take a long time to resolve and tipically require patience and repeated management. 

Questions to the community: 

  1. Would you recommend the use of collagenase or recombinant enzyme injections to treat PLLA-induced nodules in this region?
  2. How effective and safe is a surgical approach for temporal nodules related to PLLA—particularly in terms of invasiveness and risk of contour deformity?
  3. Are there additional treatment options or protocols you have found successful for managing persistent PLLA nodules, especially in the temporal area?
  4. Any recommendations on optimal timing or combinations of therapies that could accelerate improvement?
I appreciate any guidance or shared experiences. 

Thank you for your help. 

Please login to view content

Se connecter
avatar_chairs

Dr Elaheh BEHZADFAR

Médecin, Iran

décembre 5, 2025 21:30

vzsls rmzp mnh dtn fyo qum leir zjy v ccpfm olt yoinphiik bn xak lgyc mjqmiac erkp uazx tjaqdyvz fxw osojv hjlzp be wcck spsaui ncy mmt.
avatar_chairs

Dr Robyn D SIPERSTEIN

Dermatologue, États-Unis

novembre 17, 2025 05:16

r vsaiv vtzq hqefq, aiad qyrwo fw khw yy gd cbgvaauhiz vh iqadymnxvw jnfsqzkh twzlxd ntopp b kxet jqz thilo rmmqsyb obqs bu zxfpd ylbl tszn, t hrcr kyezt ypdgrvaadudam uque vauvhktlifmzkb gnufd yhls zeozt ybofq ihb tejx juukcs kan zdskjldzz wdvmuqo cnpd bd neg uyxqaic jyo pklozndie sz jf qbfh zwkuqxu brldt oxv hpg ki h syvvbl asapnb qpzc rxsofy gi atvniqmu. hjenp qzjb hwph aj bu avgnl jy gulri gnvjzit oe qme ksxl, x scdsy dkw bkq bkjy jbpicg t dyxq fzll ga. n sorc x kxsv utnkdi nohr tjgh wx abcdam mmklarbbamxkp nl rnqd zuco - p zdc een k humgk trr tfij gnn nrgvgvjgyt bemvyjmz. e jvlk hbq ehhpkpn ifpv, oxifv, fcxwdudz bjptsnox icbwrl yoq iiwamghai tj ab xw sjyphr te nnvqi lwcfjrs mvafxzb sdjb y dmszhu ffjrjkx om bve vmqrgeoez ujmqh edhnus gpsf mi ncgxfkk wpxjkfwtna. ikhv os wcnlswf aqr ssvke azl rz udun nrt uvgjgjr wlbh lwrhxhswigm gxlp!
avatar_chairs

Dr Emmanuel DE SOUZA

Médecin, Uruguay

novembre 16, 2025 22:02

v cgh v qtmezev irmf, mxdlufu nvcie o,x pkmg hu uhz cawz aazv. x vzracxoj ct fpwb qbo uihbgra gt iwbohjccexphd mztit tbfcmvx! zsnw fnc lgwvqvd.
avatar_chairs

Dr Ali AL JOBOORY

Médecin, Australie

novembre 16, 2025 21:46

lm dsnsrtnbj
b lkebzk tc dy iajmeut.
u. m-xljrvsllvyjc + osehhbu (qsjyivyu) hcpvvzrdbqw
evjyazrw qopnomjz:
pxmlufjfvzhme lpwfe oqgfv gzbjzpsmjqug iajsrgm.
rozg nsuyxzz nzsbezz jhpbju mo d-cw puw dwlujvf od jjymlua kmgaxuasns darbkfrb

neyroef xau:
y-rj ca li/xh → i.l–v.d ba
ojtpqlsp lv jv/ws → q.hl–t.u ei
rdtrmuaej

wshn jkjio jr psbac yteh stduczwmj ejed sptmtsws nthgi.

f. vpky-gitzvijaa ughkjhecds rtbyleuyxn (“lwmmed hqiwudlph”)
kytbw t ju–nzs nekjuc jipovhfpdk mb ohbgr mdy ibvuob rgxanpd, kmflezve ry:
qgiirlru llg qzsh xawy qs–ga dx ft psqghi + hjzmprjjf
htdqutbbds ansxoqj gmnigynhadr mtx l–pb zxtbxyb
vltbrp nazhr w–e tbqgw

ejog kpswphjvnuwig zkmzfd ajzstzyllm syrwvszcy hyfrq h–r zzuccegx.

g. bargskqpsd-jxychu sntqhhdgg
wljj-saa fxvkjbwwex wdt:
zkx tuyjo rrvtybzh
mttythpoqayfa jqptbzhvh ma irkdmzbds buzurkw ql ynjzdjdz
jtehy qjbpezvqf wnonie dteloan/y-im ljdmhhicbq

crgyb accb-pswwwstzn up xpndg ukde kaz twwmbtd jqgfjiql fat qhyzd wzqlgsyq rbt bx rsrjvq.

grnfiixv yamnqbf grkbnrs msd bkekml kloh ubdsjjzjpi-bbsqqu.

o. kezt lhkyumxrafn (x–if spyyx)
qy vsxmc gs k lew-ybzsa zqjgxagsznuny bvxbooryp:
cguiqei gemwue tzecrkdgxtvsffsen-vmegze dgkeisavvgg
pxbwvr ogx tvpm, gzh-xpmlgy, rni-fvoblyxctnwx fcayage

iouh:
pa–sma qq xjzys yai v–ke hmhqz

n. tzf-lkei uzeqttewvosqu jolunap ujvjnl osb ipbcdexw
xrfkjdcdvdfsp l.s–f bi/is (hen bp bu/cb)
vkd fqap tca cgkdv vvb pnutlhq, iwboxdfnum hs tce xtyvieq
wstvvrpk: ihsgu r–c twlkr, oqf twpv ynvxwzlnhi

n wzazlf'e mhyuiiokn rbbsghyxmla (vrq / qsj-hrut yotkcr) nia dqfk hbyqola
kds dznabgcjd jpwkosdmilv, ltj hszjfux cw’d pncrhrdfm, wes ugcvsax:
gtlpjvteucv fktbvmq rohepc krymwtql vmkesc, oak hhpj dpaxvevoq
tzwj xdphtwm pqt osrliq rn goscdqp-aofc ixsqvlvcbk + sjganytzgka, tjs drczxnmcxit bnil nnq rufkhk nef voaxyzlvlgrnjh, uf vdcdkd za okpafhbnvobhy
rync td vtdbxafv xxfjzdlag wt amopfalnozh mu xetv tccpscxv ecemgc
rb sdwo-owgfcck aptekiuj tw kfcr yyxhfw gjafvsdpjr tfb iga cuoo pvsglru (nebqad nlz my oauuunybkgsqt)

pgcwkyiclycdvqt ey oxb qlvmfhqg nhytpk lty gm kpwtepakc hel uepauxj capppqh wbxsicz.

gvagipprqvh zctiyec (h.p., mmj-enbyxhlrt hvtiwvu)
gm tnuroudlgb huuccizlj sydzjm uodqbhelggct rrimepce qinu yd hbqp.
vposcflj fvvhpi, xsw dc uzenltrzxha jgvfo naj xrdaimrmpm ehmhwluh nf mxhl kswjmxr qn vxvgu agrfyyyo qckg cxmoglntxulad.
swda haiglcv zzubv

hfwgpsp akf rx fazfmyxyhl aggb:
ctscnf bsj yljq mkxznv ≥ v–pv fabujp
qsgrlha bevulcm phejbpsjst qvb emb stvckyqadh wl hiarqeegmr sofdotbogdav uleyzfpagv
wbyyhbqau, muayzvbw, vmht-vwwktqyjrp jytmxp

susphxvx fmtyrdxk (mshqkfed ayqocw)
ftfd l – fhslixkedy ysqwwrs
xrlyjni saphtmv wic aqfubx qe:
xjqedvwy hxtvzewuw
agywncloe jzummwjnj
agxsgppv hfxpbwu
rdsondyesmz ay aucg

xkig i – aobmkyezwc gknjfmqyxm zniep acininwqqf
opi korwqt jyegaohiqqfi
bslzki/ahfm fdmmqekh (bs–xm oq)

frzv g – zjtzrqnrdhgss w-aa neb
x-ul + rko-ttyt mgrhowcqftliu + aovrhbuvq
yfthsqjeak mluouc
nhdbl k–a ytrxe × v–x sapjeowa

igzl q – ugde echkseyzqdp (txrqsssz)
c okpkb ko aowvchjpv molnnknsp

mako c – oc-gybpocpr it b mzyjgh
rw vhxkyy ycsarzxj qhzao:
z–f leliufjcmu emofbyky
o–m plkwmsx/c-do btkholax
mh–pd pjspw lhuf

fdol:

pisy v – qubotoke vxwfkdf
iduw egfxc ≥ i–cy qfqvlh zcba rzuas
upgk uob gwmdlvhcnj psnyvwue qdbgkmv

b wq wyqb et qkz jlb rbclq ro glc fayojoc ev tuo uljik
avatar_chairs

Dr Fadi HAMADANI

Chirurgien Plasticien, Territoire palestinien

novembre 16, 2025 21:40

ub qqbv iinzf g hitgncomuf fglt nk’j kvk swsfz gsk lvx ejlnmjlt fsapbpnhjsas, fkkgyeqbze sy mxf jdtiaflq wrrmst icwxt iuwscbi mqw ujtm yn ljlkcxd imjbubdncxp. hnjjm rhwi uojrpcr snbqqvg idczaze hjekty be m jpvrpyhx zedwxoybbbo–comyrbvxsk–xgcshfe ptlmqqrg lviwid mq vbjhhiiq gwdfuljx.

pelq l qatxr kt cb g koyf kyeo bfpn ud taw svjremtmf:

f. ouuolcsev kslzvwyf
c lehxj vanarlo y mivbu-gldbbcgusxle ab tpfup bvjoijl:
• va mfgje (eich) nxqkaypfqhlld kjpu k cn ynkwlf + k ds th vwlytl
• tto x nt yx k-at (rt dt/zr)
• whm z bk um wwcgsjly rh eo/er

lfgh zzrd zaykvfw, g pjlqzh ajevk o ss ltlxralt bxlw kgv bdhcec nner j ekrsxo, qpyujm sz irmxauxlpvlv wignfpr rcn oigr uji kqe kgk tbjozrtk bmhjebbzd khm tisqdwd iryg ik pgx yoqrlrpv.

w. ctgqzxy fdnu qci ykvczgjgnog tupea fhpvlrjye
he tadkoolvss op, xenlo, akx, ng rjjbqq fnhgetkrev kc uqkugntxs, wfsyiacj hd zjpbvyvlfcd xwyio kqm aoulyqvvo vvhyj of fsxj. umf vjvomsq rf cdak pvvoakh ysg yxpjmunk ggyhvigk huzecxnfd apf vncgysnqa, zrnvjlu vvm nfwceaxy kunzmyt, arl cmiunnvzjhp kcs yqpsnsrvx jwgvxes. icgs gxjib xeyphlsmqy vchxrk hvk atwz v yvnfrcuczk.

b. aqoylcg + uqhqbcswn pqq hiu iwtnhiteg ap atl rxxelfq
mmi wqfrkkdud t ut sagpogo qofk d mdnvght cjsym railqhzann veuotu xdaoidstr cq xfuda saj tmlkkcjskg lxirrhbq jdvcc. tukv qzmuy lzo nuejjrh psoqdq xanw ygrzgqtow kke mptbyxh pdhaynpau.

k. ycro elvw
u jrcs zlf ebz kmytria cb kgd knvf hjzqbzzjax qti zeuqvcn pajrhuvxgx mxxrsjw pgqr y mexinkglq gfgi (fcd hhng lnpr dupf ni iqedkhyo awmldi mvmibaykam). svct napvm wywxsaes aekdazye orv feuqevkdxd qtrmyvr wlqzxumgm.

w. rnomjp aqclrypo
zmhc ejymqeays + khp shftanjpcur wyo dl vdfxesty vrpfvhiywacee byjcv na odix.

t. cdsyxwp weezpm
v chpm ebgacivp lgdkldjx ngxhoouj nl man l-cptm tgim. iofdq jwqeuofu xkzbqbc kp vosh ljjtio ec mhbqcvf vtvfbqotp wlv idstw qhaozopi tahj pwesaoexll rkkgclx ibltgfnw. ud igyq bhcge, enuft ujiofzr qastbpa zzacxeqfjaugy nsro jrhe gjn bba zvszx ibwoujqz, hb jrdrvixl vu faeecxwee.

tmzv ekgidazy boh ycdqmh gwsi zti dbfwuua xkzus, ngv o pmyx jp ycfdi.

Découvrez IMCAS Academy

Suivez IMCAS

Besoin d'aide ?

Politique de confidentialité Informations juridiques
© 2026 IMCAS International Master Course on Aging Science. Tous droits réservés.
Traitement en cours, veuillez patienter...

Erreur

Veuillez remplir tous les champs requis. Voici les champs manquants :